Your browser doesn't support javascript.
loading
Phase II Study Combining Pembrolizumab with Aromatase Inhibitor in Patients with Metastatic Hormone Receptor Positive Breast Cancer.
Ge, Xuan; Yost, Susan E; Lee, Jin Sun; Frankel, Paul H; Ruel, Christopher; Cui, Yujie; Murga, Mireya; Tang, Aileen; Martinez, Norma; Chung, Samuel; Yeon, Christina; Stewart, Daphne; Li, Daneng; Rajurkar, Swapnil; Somlo, George; Mortimer, Joanne; Waisman, James; Yuan, Yuan.
  • Ge X; Department of Medical Oncology & Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA.
  • Yost SE; Department of Medical Oncology & Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA.
  • Lee JS; Department of Medical Oncology & Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA.
  • Frankel PH; Department of Statistics, City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA.
  • Ruel C; Department of Statistics, City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA.
  • Cui Y; Department of Statistics, City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA.
  • Murga M; Department of Medical Oncology & Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA.
  • Tang A; Department of Medical Oncology & Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA.
  • Martinez N; Department of Medical Oncology & Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA.
  • Chung S; Department of Medical Oncology & Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA.
  • Yeon C; Department of Medical Oncology & Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA.
  • Stewart D; Department of Medical Oncology & Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA.
  • Li D; Department of Medical Oncology & Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA.
  • Rajurkar S; Department of Medical Oncology & Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA.
  • Somlo G; Department of Medical Oncology & Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA.
  • Mortimer J; Department of Medical Oncology & Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA.
  • Waisman J; Department of Medical Oncology & Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA.
  • Yuan Y; Department of Medical Oncology & Therapeutics Research, City of Hope Comprehensive Cancer Center, Duarte, CA 91010, USA.
Cancers (Basel) ; 14(17)2022 Sep 01.
Article en En | MEDLINE | ID: mdl-36077811